Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CANCNASDAQ:FMEDNASDAQ:PABDNASDAQ:QQMG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCANCTema Oncology ETF$22.22-5.5%$25.16$22.05▼$30.11$56.66M1.1117,371 shs8,310 shsFMEDFidelity Disruptive Medicine ETF$21.70-5.4%$25.11$21.66▼$26.79$45.98M0.945,416 shs6,043 shsPABDiShares Paris-Aligned Climate MSCI World ex USA ETF$54.59+0.4%$54.60$50.46▼$57.52$99.90M0.7815,238 shs22 shsQQMGInvesco ESG NASDAQ 100 ETF$28.96-5.2%$34.12$28.20▼$36.69$59.45M1.2215,272 shs34,681 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCANCTema Oncology ETF-1.80%-4.75%-6.48%-4.85%-13.94%FMEDFidelity Disruptive Medicine ETF-1.93%-4.53%-6.53%-8.27%-6.45%PABDiShares Paris-Aligned Climate MSCI World ex USA ETF0.00%-1.12%-0.47%+6.45%+3.49%QQMGInvesco ESG NASDAQ 100 ETF-5.57%-6.49%-9.11%-13.66%+0.86%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCANCTema Oncology ETFN/AN/AN/AN/AN/AN/AN/AN/AFMEDFidelity Disruptive Medicine ETFN/AN/AN/AN/AN/AN/AN/AN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/AN/AN/AN/AN/AN/AN/AN/AQQMGInvesco ESG NASDAQ 100 ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCANCTema Oncology ETF 2.82Moderate Buy$22.22N/AFMEDFidelity Disruptive Medicine ETF 2.81Moderate Buy$21.70N/APABDiShares Paris-Aligned Climate MSCI World ex USA ETF 2.90Moderate Buy$54.59N/AQQMGInvesco ESG NASDAQ 100 ETF 2.71Moderate Buy$28.96N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCANCTema Oncology ETFN/AN/AN/AN/AN/AN/AFMEDFidelity Disruptive Medicine ETFN/AN/AN/AN/AN/AN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/AN/AN/AN/AN/AN/AQQMGInvesco ESG NASDAQ 100 ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCANCTema Oncology ETFN/AN/A23.50∞N/AN/AN/AN/AN/AFMEDFidelity Disruptive Medicine ETFN/AN/A42.35∞N/AN/AN/AN/AN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/AN/A18.55∞N/AN/AN/AN/AN/AQQMGInvesco ESG NASDAQ 100 ETFN/AN/A31.90∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCANCTema Oncology ETF$0.723.24%N/AN/AN/AFMEDFidelity Disruptive Medicine ETF$0.110.51%N/AN/AN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETF$1.462.67%N/AN/AN/AQQMGInvesco ESG NASDAQ 100 ETF$0.170.59%N/AN/AN/ALatest PABD, FMED, CANC, and QQMG DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/24/2025QQMGInvesco ESG NASDAQ 100 ETF$0.04393/24/20253/24/20253/28/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCANCTema Oncology ETFN/AFMEDFidelity Disruptive Medicine ETFN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/AQQMGInvesco ESG NASDAQ 100 ETFN/AInsider OwnershipCompanyInsider OwnershipCANCTema Oncology ETFN/AFMEDFidelity Disruptive Medicine ETFN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/AQQMGInvesco ESG NASDAQ 100 ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCANCTema Oncology ETFN/A2.55 millionN/ANot OptionableFMEDFidelity Disruptive Medicine ETFN/A2.10 millionN/ANot OptionablePABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/A1.83 millionN/AN/AQQMGInvesco ESG NASDAQ 100 ETFN/A2.05 millionN/ANot OptionablePABD, FMED, CANC, and QQMG HeadlinesRecent News About These CompaniesAn Interesting Catalyst Could Renew Interest in ESG ETFsMarch 26, 2025 | etftrends.comESG Investing Not as Controversial as Meets the EyeFebruary 14, 2025 | etftrends.comHow to Take Advantage of moves in (QQMG)January 28, 2025 | news.stocktradersdaily.com(QQMG) Pivots Trading Plans and Risk ControlsJanuary 7, 2025 | news.stocktradersdaily.comMarket for ESG, Sustainable Investing Still MassiveJanuary 2, 2025 | etftrends.com(QQMG) Trading AdviceDecember 27, 2024 | news.stocktradersdaily.comBitcoin Hits New High As Strategic Bitcoin Reserve Comes Into Focus, MicroStrategy Joins Nasdaq 100 QQQ ETFDecember 16, 2024 | msn.comPopular QQQ ETF on track for best day since surging after U.S. Election DayDecember 11, 2024 | marketwatch.comInvesco Grows QQQ Innovation Suite With 2 New ETFsDecember 4, 2024 | etftrends.com(QQMG) Investment ReportNovember 26, 2024 | news.stocktradersdaily.comLooking for Exposure to the Nasdaq-100? Consider These Two ETFsNovember 22, 2024 | msn.comAI, Sustainability Intersection Looms Large in TechNovember 20, 2024 | etftrends.comGreenwashing Focus Not Indictment of ESG InvestingNovember 6, 2024 | etftrends.comWhen the Price of (QQMG) Talks, People ListenNovember 4, 2024 | news.stocktradersdaily.comThis ETF Could Be Ideal AI PlayOctober 16, 2024 | etftrends.comESG Reality Brighter Than PerceivedOctober 11, 2024 | etftrends.comAnti-ESG Rhetoric Is Overdone, Says ExpertOctober 9, 2024 | etftrends.comSome ESG ETFs Delivering the Goods in 2024September 13, 2024 | etftrends.comInvesco NASDAQ 100 Income Advantage ETFAugust 25, 2024 | bloomberg.comInvesco EQQQ NASDAQ-100 UCITS ETF Dist (EQQU)August 13, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePABD, FMED, CANC, and QQMG Company DescriptionsTema Oncology ETF NASDAQ:CANC$22.22 -1.30 (-5.53%) As of 01:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.Fidelity Disruptive Medicine ETF NASDAQ:FMED$21.70 -1.25 (-5.43%) As of 02:22 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.iShares Paris-Aligned Climate MSCI World ex USA ETF NASDAQ:PABD$54.59 +0.23 (+0.42%) As of 04/2/2025 02:27 PM EasternThe iShares Paris-Aligned Climate MSCI World ex USA ETF (PABD) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a tier-weighted index of large- and mid-cap stocks in developed markets excluding the US. The fund utilizes ESG criteria aligned with the Paris Climate Agreement when selecting and weighing securities. PABD was launched on Feb 8, 2022 and is issued by BlackRock.Invesco ESG NASDAQ 100 ETF NASDAQ:QQMG$28.96 -1.57 (-5.16%) As of 02:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Invesco ESG NASDAQ 100 ETF (QQMG) is an exchange-traded fund that is based on the NASDAQ-100 ESG index. The fund tracks an index of NASDAQ-100 stocks screened and weighted based on various environmental, social, and governance criteria. QQMG was launched on Oct 27, 2021 and is managed by Invesco. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Archer Aviation’s Africa Deal Could Boost ACHR Stock The Ecosystem Edge: Joby's Competitive Advantage Intel’s Big Bet on 18A: Will Lip-Bu Tan’s Vision Pay Off? Lamb Weston Stock Rises, Earnings Provide Calm Amidst Chaos Sportsman’s Warehouse Trading Volume Spike Signals Opportunity Broadcom’s VMware Strategy Could Fuel the Next AVGO Rally Arm Holdings Aims for 50% Data Center Market Share Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
